Skip to main content

Psychiatry, Mental Health and Addictions

61
Publications
63.93
%Q1
542
Number of citations
68.63
% Open Access Publications
21
Ongoing Projects
2
Number of Presented Theses
22
Number of Active Clinical Trials
The Psychiatry, Mental Health, and Addictions Group is a multidisciplinary team that, over the past 15 years, has focused on researching clinical, therapeutic, and etiopathogenic aspects of Neurodevelopmental Disorders (e.g., ADHD, Autism, Fetal Alcohol Syndrome), Personality Disorders (e.g., Borderline Personality Disorder), Addictive Behaviours (e.g., Dual Pathology, Smoking), Transcultural Psychiatry, Interconsultation Psychiatry, Depressive Disorder, Perinatal Psychiatry, and Child Sexual Abuse and Maltreatment. Internationally, it participates in and/or coordinates several European projects, and nationally, it is the Group 27 of CIBERSAM (Centre for Biomedical Research in Mental Health Network). This year, the group has published over 50 scientific articles (36 in Q1 journals), launched more than 10 clinical trials (on Autism, Major Depression, Bipolar Disorder, Psychosis, Obesity, ADHD, among others), and has secured funding from national and international competitive calls.

eCORE

  • Brain & Mind and Behaviour
  • Woman & Child Health & Rare Diseases

Team

Group Leader
Josep Antoni Ramos-Quiroga

Principal Investigator (PI)
Marta Ribasés Haro, Anna Beneria González, Mª Dolores Braquehais Conesa, Eugeni Bruguera Cortada, Natalia Calvo Piñero, Francisco Collazos Sanchez, Marc Ferrer Vinardell, Sara Guila Fidel Kinori, Núria Gómez Barros, Lara Grau Lopez, Carlos Jacas Escarcellé, Pilar Lusilla Palacios, José Antonio Navarro Sanchís, Gemma Parramon Puig, Marta Quesada Franco, Vanesa Richarte Fernández, Amanda Rodríguez Urrutia, María Soler, Christian Fadeuilhe, Laura Gisbert

Researchers
Silvia Alemany Sierra, Dimitra Tatiana Anastasiadou, Mª Sonsoles Cepeda Diez, Raquel Vidal Estrada, Silvia Amoretti, Jorge Lugo Marin, Gemma Nieva Rifa, Elena Ros, Constanza Daigré, Montserrat Corrales, Gara Arteaga Henriquez, Laura Maran, Gemma Español

PhD Students
Christina Regales Peco, Miguel Angel Sandonis Vicente, Pedro Serrano Pérez, Felipe Palma, Natàlia Llonga

Lab Technicians
Pau Carabí Gassol, Valeria Macias Chimborazo

Nursing and Technical Staff
Montserrat Fabregat Garcia, Pol Ibañez Jimenez, Estela García Egea, Judit Palacio Sanchez, Carolina Ramos Sayalero, Imanol Setien Ramos, Silvia Muñoz, Àlex Rué Jiménez, Berta Roig, Sara Fernandez Torrelles, Raquel Ibarz López

Selected Publications

Cabana-Dominguez J, Bosch R, Soler Artigas M, Alemany S, Llonga N, Vilar-Ribo L, Carabi-Gassol P, Arribas L, Macias-Chimborazo V, Espanol-Martin G, Del Castillo C, Martinez L, Pagerols M, Pagespetit E, Prat R, Puigbo J, Ramos-Quiroga JA, Casas M, Ribases M
Dissecting the polygenic contribution of attention-deficit/hyperactivity disorder and autism spectrum disorder on school performance by their relationship with educational attainment.
Mol Psychiatry. 2024 Nov;29(11):3503-3515. . Epub 2024 May 23.
DOI: 10.1038/s41380-024-02582-w
IF: 9.6

Arteaga-Henriquez G, Ramos-Sayalero C, Ibanez-Jimenez P, Karina Rosales-Ortiz, Kilencz T, Schiweck C, Schnorr I, Siegl A, Arias-Vasquez A, Bitter I, Fadeuilhe C, Ferrer M, Lavebratt C, Matura S, Reif A, Rethelyi JM, Richarte V, Rommelse N, Antoni Ramos-Quiroga
Efficacy of a synbiotic in the management of adults with Attention-Deficit and Hyperactivity Disorder and/or Borderline Personality Disorder, and high levels of irritability: Results from a multicenter, randomized, placebo-controlled, ''basket'' trial.
Brain Behav Immun. 2024 Aug;120:360-371. Epub 2024 Jun 15.
DOI: 10.1016/j.bbi.2024.06.012.
IF: 8.8

Soto-Angona O, Fortea A, Fortea L, Martinez-Ramirez M, Santamarina E, Lopez FJG, Knudsen GM, Ona G
Do classic psychedelics increase the risk of seizures? A scoping review.
Eur Neuropsychopharmacol. 2024 Aug;85:35-42. Epub 2024 Jun 24.
DOI: 10.1016/j.euroneuro.2024.05.002.
IF: 6.1

Vilar-Ribo L, Cabana-Dominguez J, Alemany S, Llonga N, Arribas L, Grau-Lopez L, Daigre C, Cormand B, Fernandez-Castillo N, Ramos-Quiroga JA, Soler Artigas M, Ribases M
Disentangling heterogeneity in substance use disorder: Insights from genome-wide polygenic scores.
Transl Psychiatry. 2024 May 29;14(1):221.
DOI: 10.1038/s41398-024-02923-x.
IF: 5.8

Restoy D, Oriol-Escude M, Alonzo-Castillo T, Magan-Maganto M, Canal-Bedia R, Diez-Villoria E, Gisbert-Gustemps L, Setien-Ramos I, Martinez-Ramirez M, Ramos-Quiroga JA, Lugo-Marin J
Emotion regulation and emotion dysregulation in children and adolescents with Autism Spectrum Disorder: A meta-analysis of evaluation and intervention studies.
Clin Psychol Rev. 2024 Apr;109:102410. Epub 2024 Feb 21.
DOI: 10.1016/j.cpr.2024.102410.
IF: 13.7

Selected Projects

Programa Formació Professional Ocupacional Dual
Principal Investigator: Francisco Collazos
Agency: SOC (Convocatoria DUAL
Funding: 331,827.58 €
Period: 2024-2026

Implementació de la figura d’Agent Comunitari de Salut Mental (AC-SM) per al suport de joves migrats / Implementación de la figura del Agente Comunitario de Salud Mental (AC-SM) para el soporte de jóvenes migrantes (CY23-00771)
Principal Investigator: Francisco Collazos
Agency: Fundació La Caixa
Funding: 30,000 €
Period: 2024-2026

Bridging the gap in the study of bipolar disorder and attention deficit hyperactivity disorder: impact of cognitiVE reserve and funCtioning in a newly designed treatment intervenTion for comORbidity (VECTOR) - PI24/00671
Principal Investigator: Silvia Amoretti
Agency: Fondo de Investigación Sanitaria (FIS), Instituto de Salud Carlos III, Ministerio de Economía y Competitividad (MICINN)
Funding: 72,500 €
Period: 2024-2027

Explorando la base epigenética y Ambiental de los problemas externalizantes e internalizantes (EPI-ENVI) - PI24/00195
Principal Investigator: Silvia Alemany
Agency: Fondo de Investigación Sanitaria (FIS), Instituto de Salud Carlos III, Ministerio de Economía y Competitividad (MICINN)
Funding: 102,500€
Period: 2024 - 2027

Immunopsychiatry Research Line Project
Principal Investigator: JA Ramos-Quiroga
Agency: BOOSTING OF OUTSTANDING SCIENTIFIC TEAMS (BOOST) CALL 2024
Funding: 40,000 €
Period: 2024-2025

VHIR Annual Report 2024